Business Description
Genpharmasec Ltd
ISIN : INE861N01036
Total Employee Number:
10Compare
Compare
Traded in other countries / regions
531592.India IPO Date
1996-04-15Description
Genpharmasec Ltd is engaged in pharmaceutical activities and services. The company operates in three reportable segments, namely: Diagnostic Pharma Equipment, Trading in Securities, and Laboratory Testing. The company generates the majority of its revenue from the Diagnostic Pharma Equipment Segment. Geographically, the company generates the majority of its revenue from the Domestic market.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.32 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.53 | |||||
Debt-to-EBITDA | 7.98 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 1.82 | |||||
Beneish M-Score | -0.07 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 66.4 | |||||
3-Year EBITDA Growth Rate | 114.5 | |||||
3-Year EPS without NRI Growth Rate | -23.1 | |||||
3-Year FCF Growth Rate | -69.6 | |||||
3-Year Book Growth Rate | 53.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.78 | |||||
9-Day RSI | 46.22 | |||||
14-Day RSI | 44.81 | |||||
3-1 Month Momentum % | -9.84 | |||||
6-1 Month Momentum % | -5.98 | |||||
12-1 Month Momentum % | -44.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.71 | |||||
Quick Ratio | 1.42 | |||||
Cash Ratio | 0.23 | |||||
Days Inventory | 39.56 | |||||
Days Sales Outstanding | 58.61 | |||||
Days Payable | 75.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -31.68 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 8.46 | |||||
Operating Margin % | -0.68 | |||||
Net Margin % | 0.6 | |||||
EBITDA Margin % | 3.13 | |||||
FCF Margin % | -12.92 | |||||
OCF Margin % | -12.55 | |||||
ROE % | 1.27 | |||||
ROA % | 0.73 | |||||
ROIC % | -0.69 | |||||
3-Year ROIIC % | -0.8 | |||||
ROC (Joel Greenblatt) % | 6.41 | |||||
ROCE % | 2.82 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
Shiller PE Ratio | 12.23 | |||||
PS Ratio | 0.43 | |||||
PB Ratio | 0.86 | |||||
Price-to-Tangible-Book | 1.2 | |||||
EV-to-EBIT | 36.58 | |||||
EV-to-EBITDA | 18.47 | |||||
EV-to-Revenue | 0.57 | |||||
EV-to-FCF | -4.41 | |||||
Price-to-GF-Value | 0.1 | |||||
| Price-to-Net-Current-Asset-Value | 6.5 | |||||
Earnings Yield (Greenblatt) % | 2.73 | |||||
FCF Yield % | -31.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genpharmasec Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,399.376 | ||
| EPS (TTM) (₹) | - | ||
| Beta | 1.4887 | ||
| 3-Year Sharpe Ratio | 0.01 | ||
| 3-Year Sortino Ratio | 0.02 | ||
| Volatility % | 72.8 | ||
| 14-Day RSI | 44.81 | ||
| 14-Day ATR (₹) | 0.054458 | ||
| 20-Day SMA (₹) | 1.053 | ||
| 12-1 Month Momentum % | -44.72 | ||
| 52-Week Range (₹) | 0.76 - 2.2 | ||
| Shares Outstanding (Mil) | 553.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genpharmasec Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genpharmasec Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 10:1 Stock Split | 2019-04-11 | 9.37 (+0.29%) | ||
| 0.05:1 Stock Split | 2016-08-03 | 3.30 (+0.00%) |
Show
Entries
Genpharmasec Ltd Frequently Asked Questions
What is Genpharmasec Ltd(BOM:531592)'s stock price today?
The current price of BOM:531592 is ₹1.04. The 52 week high of BOM:531592 is ₹2.20 and 52 week low is ₹0.76.
When is next earnings date of Genpharmasec Ltd(BOM:531592)?
The next earnings date of Genpharmasec Ltd(BOM:531592) is .
Does Genpharmasec Ltd(BOM:531592) pay dividends? If so, how much?
Genpharmasec Ltd(BOM:531592) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Genpharmasec Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers